Lukas F. Mager
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Microbial metabolite facilitates virus control: inosine and T cells curb early-life influenza infection.
Journal: Signal transduction and targeted therapy
Published: July 16, 2025
Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 10, 2025
Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity.
Journal: Cell reports
Published: February 13, 2025
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer.
Journal: Cancer & metabolism
Published: December 05, 2024
Interaction of microbiota, mucosal malignancies, and immunotherapy-Mechanistic insights.
Journal: Mucosal immunology
Published: December 29, 2023
Intestinal colonization regulates systemic anti-commensal immune sensitivity and hyperreactivity.
Journal: Frontiers in immunology
Published: August 28, 2022
Exercise and Prebiotic Fiber Provide Gut Microbiota-Driven Benefit in a Survivor to Germ-Free Mouse Translational Model of Breast Cancer.
Journal: Cancers
Published: April 07, 2022
Photonic Excitation of a Micromechanical Cantilever in Electrostatic Fields.
Journal: Physical review letters
Published: July 17, 2020
Impact of the microbiome on tumor immunity.
Journal: Current opinion in immunology
Published: July 16, 2020
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.
Journal: Science (New York, N.Y.)
Published: April 20, 2020
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
Journal: Mucosal immunology
Published: January 25, 2019
Last Updated: 09/26/2026